Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Genetic immunisation by liver stage antigen 3 protects chimpanzees against malaria despite low immune responses.

Daubersies P, Ollomo B, Sauzet JP, Brahimi K, Perlaza BL, Eling W, Moukana H, Rouquet P, de Taisne C, Druilhe P.

PLoS One. 2008 Jul 16;3(7):e2659. doi: 10.1371/journal.pone.0002659.

2.

Delivery technologies for human vaccines.

Moingeon P, de Taisne C, Almond J.

Br Med Bull. 2002;62:29-44. Review.

PMID:
12176848
3.

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

Wang R, Doolan DL, Le TP, Hedstrom RC, Coonan KM, Charoenvit Y, Jones TR, Hobart P, Margalith M, Ng J, Weiss WR, Sedegah M, de Taisne C, Norman JA, Hoffman SL.

Science. 1998 Oct 16;282(5388):476-80.

4.

Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

Ockenhouse CF, Sun PF, Lanar DE, Wellde BT, Hall BT, Kester K, Stoute JA, Magill A, Krzych U, Farley L, Wirtz RA, Sadoff JC, Kaslow DC, Kumar S, Church LW, Crutcher JM, Wizel B, Hoffman S, Lalvani A, Hill AV, Tine JA, Guito KP, de Taisne C, Anders R, Ballou WR, et al.

J Infect Dis. 1998 Jun;177(6):1664-73.

PMID:
9607847
5.

NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

Tine JA, Lanar DE, Smith DM, Wellde BT, Schultheiss P, Ware LA, Kauffman EB, Wirtz RA, De Taisne C, Hui GS, Chang SP, Church P, Hollingdale MR, Kaslow DC, Hoffman S, Guito KP, Ballou WR, Sadoff JC, Paoletti E.

Infect Immun. 1996 Sep;64(9):3833-44.

6.

African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses.

Govorkova EA, Murti G, Meignier B, de Taisne C, Webster RG.

J Virol. 1996 Aug;70(8):5519-24.

7.

Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria.

Lanar DE, Tine JA, de Taisne C, Seguin MC, Cox WI, Winslow JP, Ware LA, Kauffman EB, Gordon D, Ballou WR, Paoletti E, Sadoff JC.

Infect Immun. 1996 May;64(5):1666-71.

8.

Immunogenicity of the Plasmodium falciparum serine repeat antigen (p126) expressed by vaccinia virus.

Tine JA, Conseil V, Delplace P, De Taisne C, Camus D, Paoletti E.

Infect Immun. 1993 Sep;61(9):3933-41.

9.

Immunogenicity and antigenicity of the N-term repeat amino acid sequence of the Plasmodium falciparum P126 antigen.

Banic DM, Bossus M, Delplace P, Tartar A, Gras-Masse H, Conseil V, Mazingue C, de Taisne C, Camus D.

Mem Inst Oswaldo Cruz. 1992;87 Suppl 3:159-62.

10.

Chromosomal localization of the human proto-oncogene c-ets.

de Taisne C, Gegonne A, Stehelin D, Bernheim A, Berger R.

Nature. 1984 Aug 16-22;310(5978):581-3.

PMID:
6462246
11.

A putative second cell-derived oncogene of the avian leukaemia retrovirus E26.

Leprince D, Gegonne A, Coll J, de Taisne C, Schneeberger A, Lagrou C, Stehelin D.

Nature. 1983 Nov 24-30;306(5941):395-7.

PMID:
6316156
12.
13.

The human DNA locus related to the oncogene myb of avian myeloblastosis virus (AMV): molecular cloning and structural characterization.

Leprince D, Saule S, de Taisne C, Gegonne A, Begue A, Righi M, Stehelin D.

EMBO J. 1983;2(7):1073-8.

14.

A reexamination of the buoyant density of chicken ribosomal DNA.

Rode A, de Taisne C, Hartman C.

Biochem Biophys Res Commun. 1981 Dec 31;103(4):1343-8. No abstract available.

PMID:
7332597

Supplemental Content

Loading ...
Support Center